AC
PTCT icon

Allstate Corporation’s PTC Therapeutics PTCT Stock Holding History

Allstate Corporation’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$438K Buy
5,368
+1,785
+50% +$129K ﹤0.01% 1083
2026
Q1 		$244K Buy
+3,583
New +$254K ﹤0.01% 1095

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Allstate Corporation's PTCT Position: Q2 2026 in Review

Allstate Corporation increased its PTC Therapeutics (PTCT) stake by 50% in Q2 2026, buying an estimated $129K and bringing the position to 5,368 shares worth $438K. The position accounts for ﹤0.01% of the portfolio, ranked #1083.

Allstate Corporation first reported a position in PTCT in Q1 2026 and has held it in 2 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Allstate Corporation held 5,368 shares of PTC Therapeutics worth $438K as of Q2 2026.
  • Allstate Corporation bought 1,785 PTC Therapeutics shares in Q2 2026, an estimated $129K.
  • PTC Therapeutics made up ﹤0.01% of Allstate Corporation's portfolio in Q2 2026, its #1083 holding.
  • Allstate Corporation first reported a position in PTC Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.